We further confirmed the previous findings that COX-2 exhibits higher expression in tumor areas and that both the CysLT2 receptor and 15-PGDH are expressed at higher levels in normal areas compared to tumor areas in matched sample pairs from patients with colon cancer. Here, HPGD is linked to malignant colon neoplasm.